Bariatric surgery causes high rates of remission of type 2 diabetes; however, the mechanisms remain unresolved. A new study identifies cholic-acid-7-sulfate as a novel contributor to the metabolic benefits of bariatric surgery and an attractive target for treatment of type 2 diabetes.
References
Chaudhari, S. N. et al. Nat. Chem. Biol. https://doi.org/10.1038/s41589-020-0604-z (2020).
Pories, W. J. et al. Ann. Surg. 222, 339–352 (1995).
Ding, L. et al. Hepatology 64, 760–773 (2016).
McGavigan, A. K. et al. Gut 66, 226–234 (2017).
Ryan, K. K. et al. Nature 509, 183–188 (2014).
Thomas, C. et al. Cell Metab. 10, 167–177 (2009).
Vassileva, G. et al. Biochem. J. 398, 423–430 (2006).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing interests.
Rights and permissions
About this article
Cite this article
Cummings, B.P. Bariatric surgery works through a novel bile acid. Nat Chem Biol 17, 5–6 (2021). https://doi.org/10.1038/s41589-020-0648-0
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41589-020-0648-0
- Springer Nature America, Inc.